Signant Health

Leading technology without limits: Global pharmaceutical leaders rely on our comprehensive #eCOA, eClinRO, and #RTSM solutions for reliable evidence generation. No surprises, just flexible tech backed by expert teams. Explore industry-standard solutions: https://hubs.li/Q02Yg5M70

Struggling with data quality in your clinical trials? Boost endpoint reliability with our industry-leading ePRO and complex eClinRO data capture solutions for any trial. No surprises, just reliable performance: https://hubs.li/Q02Z3l220

ICYMI: Our #CTAD24 posters highlight common challenges associated with obtaining accurate clinician ratings?in #alzheimers #clinicaltrials. Download them and let us know in the comments how you ensure endpoint reliability. https://hubs.li/Q02YVMWk0 david miller, Alan Kott, Xingmei Wang

We're looking forward to Clinical Trials in Oncology. Join us in Munich December 3-4 to explore strategies for successful collaboration and practical solutions to enhance your #oncologytrials. Let’s tackle operational challenges together and advance #oncology research. See you there! #OncologyEurope

Driving #PRO completion rates is a vital element of successful ePRO implementation to enable reliable inference making. Join Signant’s Manuela Bossi, PhD at #ISPOREurope as she presents a data-driven evaluation of how completion reminder alarms within Signant’s ePRO solution impact eDiary completion behavior. Learn about just one of the ways we help to drive high completion rates and high-quality data: https://hubs.li/Q02YlNkC0

At Signant, we continue to drive good science and high-quality data in #oncology #clinicaltrials. Join Bill Byrom as he explores key topics related to collection of patient-reported outcomes in early phase and phase III cancer trials at #ISPOREurope. With Rohini Sen, Ph.D (AbbVie) and Ari Gnanasakthy (RTI), he will explore unanswered methodology questions related to the FDA Final Guidance on Core patient-reported outcomes in cancer trials; and practical approaches to using PROs to characterize tolerability for optimal dose selection in early phase. https://hubs.li/Q02Y3xZx0

Deciding between app or web for ePRO? We break down the key factors to consider when choosing the right modality for your study. Whether it’s at home or on-site, ensure data quality and participant convenience: https://lnkd.in/eSqwF3Rv #ePRO #ClinicalTrials

As supply chains grow and third-party vendors multiply, maintaining traceability is more challenging than ever. In our latest blog post, we dive into how fragmented inventory impacts #clinicaltrial efficiency and how our GxP Inventory solution acts as a single source of truth, simplifying complex global #supplychains. Read more: https://hubs.li/Q02XVxb-0

Does your clinical #supplychain management process depend on disconnected data sources? There's a better way: Learn from experts how a centralized approach de-risks your supply chain and reduces costs: https://hubs.li/Q02XNdVY0

??Take a tour through Signant SmartSignals? Unified Platform to see how you can seamlessly transition from EDC to RTSM, eConsent, eCOA, TeleVisits, and Participant Tracker: https://hubs.ly/Q02Xhl3K0